{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T05:15:34Z","timestamp":1740287734246,"version":"3.37.3"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1093\/toxsci\/kfq200","type":"journal-article","created":{"date-parts":[[2010,7,9]],"date-time":"2010-07-09T02:43:05Z","timestamp":1278643385000},"page":"493-504","source":"Crossref","is-referenced-by-count":3,"title":["Diabetogenic Effect of a Series of Tricyclic Delta Opioid Agonists Structurally Related to Cyproheptadine"],"prefix":"10.1093","volume":"117","author":[{"given":"Ellen E.","family":"Codd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stewart","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaozhong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen M.","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond W.","family":"Colburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy P.","family":"Coogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott L.","family":"Dax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"DeCorte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kemmerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund K.","family":"LeGrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Lenhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelique M.","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Mabus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"McMillian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"McNally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Dennis J.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sui-Po","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,7,8]]},"reference":[{"year":"2002","key":"key\n\t\t\t\t20170314064026_bib1","article-title":"\u201cFunctional Anatomy of the Endocrine Pancreas\u201d"},{"key":"key\n\t\t\t\t20170314064026_bib2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/jmg.40.9.685","article-title":"Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3","volume":"40","year":"2003","journal-title":"J. Med. Genet."},{"key":"key\n\t\t\t\t20170314064026_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00122648","article-title":"Cyproheptadine metabolites inhibit proinsulin and insulin biosynthesis and insulin release in isolated rat pancreatic islets","volume":"5","year":"1989","journal-title":"Cell Biol. Toxicol."},{"key":"key\n\t\t\t\t20170314064026_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-3565(25)20994-6","article-title":"Evidence that drug metabolites are involved in cyproheptadine-induced loss of pancreatic insulin","volume":"246","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20170314064026_bib5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1124\/jpet.106.104208","article-title":"The novel, orally active, delta opioid RWJ-394674 is biotransformed to the potent Mu opioid RWJ-413216","volume":"318","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20170314064026_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/jpet.108.146969","article-title":"JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence","volume":"329","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20170314064026_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/78085","article-title":"EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome","volume":"25","year":"2000","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170314064026_bib8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/jm00330a022","article-title":"Structure-activity relations in the cyproheptadine series","volume":"8","year":"1965","journal-title":"J. Med. Chem."},{"key":"key\n\t\t\t\t20170314064026_bib9"},{"key":"key\n\t\t\t\t20170314064026_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/toxsci\/kfh113","article-title":"Inhibition of insulin synthesis by cyproheptadine: effects on translation","volume":"79","year":"2004","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t20170314064026_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0300-483X(77)90058-0","article-title":"Isomeric specificity of diphenylmethylpiperidine in the production of rat pancreatic islet cell toxicity","volume":"7","year":"1977","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t20170314064026_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0090-9556(25)05613-2","article-title":"Disposition of cyproheptadine in rats, mice, and humans and identification of a stable epoxide metabolite","volume":"3","year":"1975","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20170314064026_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0090-9556(24)12015-6","article-title":"Physiological disposition and urinary metabolites of cyproheptadine in the dog, rat, and cat","volume":"2","year":"1974","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20170314064026_bib14","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1248\/bpb.16.1276","article-title":"Pharmacokinetics of cyproheptadine and its metabolites in rats","volume":"16","year":"1993","journal-title":"Biol. Pharm. Bull."},{"key":"key\n\t\t\t\t20170314064026_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-2007-1019266","article-title":"Cyproheptadine inhibits (pro)insulin biosynthesis and secretion of isolated human pancreatic islets","volume":"13","year":"1981","journal-title":"Horm. Metab. Res."},{"key":"key\n\t\t\t\t20170314064026_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02098995","article-title":"The effects of cyproheptadine on glucose tolerance and pancreatic islets in rats","volume":"18","year":"1981","journal-title":"Acta Diabetol. Lat."},{"key":"key\n\t\t\t\t20170314064026_bib17","first-page":"353","article-title":"Pancreatic toxicants detected using RINm5F cells","volume":"96","year":"2007","journal-title":"Toxicologist"},{"key":"key\n\t\t\t\t20170314064026_bib18","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/0006-2952(90)90619-V","article-title":"Cyproheptadine-induced alterations in clonal insulin-producing cell lines","volume":"39","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"key\n\t\t\t\t20170314064026_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jbt.2570080304","article-title":"Inhibition of insulin production by cyproheptadine in RINm5F rat insulinoma cells","volume":"8","year":"1993","journal-title":"J. Biochem. Toxicol."},{"key":"key\n\t\t\t\t20170314064026_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/toxsci\/kfn108","article-title":"Mechanistic investigation of N, N-diethyl-4-(phenyl-piperidin-4-ylidenemethyl)-benzamide-induced insulin depletion in the rat and RINm5F cells","volume":"105","year":"2008","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t20170314064026_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0090-9556(25)05713-7","article-title":"Human metabolism of cyproheptadine","volume":"3","year":"1975","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20170314064026_bib22","first-page":"587","article-title":"Cyproheptadine-induced depletion of insulin in the rat","volume":"193","year":"1975","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20170314064026_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/15513819709168589","article-title":"Autopsy findings in the Wolcott-Rallison syndrome","volume":"17","year":"1997","journal-title":"Pediatr. Pathol. Lab. Med."},{"key":"key\n\t\t\t\t20170314064026_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jcp.21543","article-title":"PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation","volume":"217","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"key\n\t\t\t\t20170314064026_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3476(72)80596-1","article-title":"Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia","volume":"80","year":"1972","journal-title":"J. Pediatr."},{"key":"key\n\t\t\t\t20170314064026_bib26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0041-008X(71)90106-2","article-title":"Species dependent pancreatic islet toxicity produced by cyproheptadine. Alterations in beta cell structure and function","volume":"19","year":"1971","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"key\n\t\t\t\t20170314064026_bib27","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/MCB.22.11.3864-3874.2002","article-title":"The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas","volume":"22","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170314064026_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cmet.2006.11.002","article-title":"PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis","volume":"4","year":"2006","journal-title":"Cell Metab."}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/117\/2\/493\/10977074\/kfq200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T19:51:15Z","timestamp":1740253875000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/1640502\/Diabetogenic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,8]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,7,8]]},"published-print":{"date-parts":[[2010,10]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfq200","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"type":"print","value":"1096-6080"},{"type":"electronic","value":"1096-0929"}],"subject":[],"published":{"date-parts":[[2010,7,8]]}}}